Tag: raw materials

Investigation of Polymorphic Form Inconsistency During Supplier Transition in Pharmaceutical Manufacturing In the dynamic landscape of pharmaceutical manufacturing, polymorphic form inconsistency can lead to significant quality issues, particularly during a…

Investigating Residual Solvent Excursions in Pharmaceutical Manufacturing In pharmaceutical manufacturing, ensuring compliance with quality standards for raw materials is critical. One common issue that can arise is the presence of…

Assessing Regulatory Impacts of Polymorphic Form Inconsistencies in Stability Studies In the pharmaceutical manufacturing environment, consistent polymorphic form is essential for ensuring that active pharmaceutical ingredients (APIs) meet their specifications…

Investigating Residual Solvent Excursions during Stability Studies: A Comprehensive Approach In pharmaceutical manufacturing, residual solvent excursions during stability studies can pose significant risks to product quality, compliance, and regulatory inspection…

Addressing Residual Solvent Excursions During Supplier Changes: A Comprehensive Investigation In the pharmaceutical industry, excursions related to residual solvents during raw material supplier changes can present serious challenges, potentially impacting…

Investigating API Assay Variability During Regulatory Inspection: A CAPA Approach Variability in Active Pharmaceutical Ingredient (API) assays that exceeds trend limits can pose significant challenges during regulatory inspections, raising concerns…

Addressing Impurity Profile Drift during Incoming Testing to Avoid Batch Disparities Encountering an impurity profile drift during incoming testing can trigger alarms within any pharmaceutical manufacturing facility. With stringent regulatory…

Understanding Residual Solvent Excursions in Deviation Investigations to Prevent Batch Rejections In pharmaceutical manufacturing, the detection of residual solvent excursions can prompt significant concern, often leading to batch rejection or…

Framework for Investigating Impurity Profile Drift Detected in Stability Studies In the world of pharmaceutical manufacturing, detecting an impurity profile drift during stability studies can trigger significant concerns regarding compliance,…

Understanding How Particle Size Variability Affects Regulatory Performance In pharmaceutical manufacturing, maintaining consistent particle size of raw materials, especially Active Pharmaceutical Ingredients (APIs) and excipients, is critical for ensuring product…

Framework for Investigating Impurity Profile Drift Detected During Incoming Testing The detection of impurity profile drift during incoming testing poses a significant challenge for manufacturing and quality assurance teams within…

Managing Residual Solvent Excursions During Supplier Change to Avoid Batch Rejection Manufacturers frequently face challenges related to residual solvent levels during supplier changes, threatening compliance with regulatory expectations and risking…